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  1）PIPC were三n亡raven・usly administered亡・24 pa亡ients with c・mplicated urinary tract infecti・ns
in daily doses of 4 g for 5 days and results obtained were excellent in 8 cases， good in 7 cases and poor
in 9 cases．
  2） The drug w． as effective to Pse”domonas and Serral’ia （effective rate 67％ in both）．
  3） 2 g doses of PIPC were intravenously administered to three patients， twc with unilateral renal
impairment and one with impairment of solitary kidney by a single shot． Urinary concentration
and excretion rate of ？IPC were lo“T in urine from disecfi‘sed kidneys．
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Table 1．Results of glinical trial with PIPC （＊ ×400）．
鰍sinｴ，、鵠n UrinarytindingNo． Cose Sex Age Diegno7is BeずQre 奮re（ヌ寸rnefit
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Table 2． Urinary concentration and excretion of PIPC in patients－with renal insuMciency．
No．1CN．M．｝ No，2 （N．T．｝ No．5 tM， K．）
Healthy sideSuffered sideHeaithy sideSutfered slaeRemaining kidney
鞭臨謝鞭と臨蹴籍馳臨譲婿響脇器辮臨鵬．
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9例，次いでPseudomonas 6例， Proteus 3例， SlaPh・

































































         （1978年10月2日迅速掲載受付）
1）複雑性尿路感染症の24例にPIPGの臨床効果
 訂正：Table 1の6列目のUnderlysingはUnderlyingの， HydronephritisはHydronephrosis
の誤りです．
